Hikma Pharmaceuticals (LSE:HIK)

UK company
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - HIK

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - HIK

  • Market Cap£4.515bn
  • SymbolLSE:HIK
  • IndustryHealthcare
  • SectorDrug Manufacturers - Specialty & Generic
  • Currency
  • ISINGB00B0LCW083

Company Profile

Founded in the Middle East and with headquarters in London, Hikma manufactures generic and in-licensed pharmaceuticals. The firm operates in three segments: injectables, generics, branded, and other, which comprise most of the company's revenue at about 40%, 33%, and 26%, respectively. About 63%, 32%, and 6% of Hikma’s sales are based in the U.S., Middle East, North Africa, and Europe, and Other.Hikma Pharmaceuticals PLC develops, manufactures and markets a broad range of branded and non-branded generic pharmaceutical products across the US, the MENA region, and Europe.

Latest HIK news

Currently there for this company. Visit our news hub for other news .

HIK Regulatory news

Currently there for this company. Visit our news hub for other news .